In December 2025, this breakthrough technology expanded to weight management when the FDA approved the Wegovy pill the first oral GLP-1 medication specifically for obesity and weight loss
You May Also Like Retatrutide Available: 5mg, 15mg, 30mg, 60mg, 10mg, 20mg, 40mg, 50mg Tirzepatide Available: 2mg, 20mg, 40mg, 15mg, 30mg, 10mg, 50mg, 60mg, 5mg Mazdutide Available: 5mg, 10mg Ipamorelin Available: 2mg, 5mg, 10mg, 20mg Semaglutide Available: 15mg, 20mg, 50mg, 5mg, 10mg, 30mg Cagrilintide Available: 5mg, 10mg
New NDSUSanford study to track real-world effects of GLP-1 meds Researchers will track weight, muscle loss, mental health and quality of life in patients starting GLP-1 medications
SmagaIPomiernyBKrzyanowskaWPomierny-ChamiooLMiszkielJNiedzielskaEet alN-acetylcysteine possesses antidepressant-like activity through reduction of oxidative stress: behavioral and biochemical analyses in rats